Delivery Order SPE2DE24D0013-SPE2D625F3FTQ
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $2,760 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on August 20, 2025, with an ultimate completion date of August 27, 2025. This contract carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, which enable the company to provide molecular diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid, a molecular diagnostic solutions manufacturer headquartered in Sunnyvale, California, received a delivery order award valued at $5,443.58 under contract number XPRSMVP-10 from the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which was not set-aside for any specific business category, was awarded on August 21, 2025, with an ultimate completion date of August 28, 2025. The work will be performed in Sunnyvale, California, and represents...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,104 on September 11, 2025, with an ultimate completion date of September 18, 2025. The contract, designated XPRSTREPA-10, was issued by the Medical Supply Chain division of the Defense Logistics Agency with no set-aside designation. The place of performance is Sunnyvale, California, and the low contract value suggests this represents a specific...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $6,390 on September 9, 2025, by the Defense Department's Medical Supply Chain office. The delivery order, designated XPRS4PLEX-10, has an ultimate completion date of September 16, 2025, and involves performance at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a discrete procurement action under the company's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,194.60 by the Defense Logistics Agency's Medical Supply Chain division on September 11, 2025. The contract calls for delivery of a Kit Xpert Spec CLT 10 Test Cartridge with general respiratory/rhino virus detection capability, representing a firm fixed-price procurement with no set-aside designation. Performance is scheduled for completion by September 18, 2025,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, has been awarded a delivery order valued at $1,605.00 under contract GXMRSA-NXG-10, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is funded by the Defense Medical Supply Chain, a defense-focused federal agency. The award represents Cepheid's continued provision of molecular diagnostic technologies and services to the...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3FTQDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a firm fixed-price delivery order valued at $1,190.28 from the Defense Logistics Agency (DLA), which operates under the Medical Supply Chain function. The contract, awarded on September 11, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This delivery order is executed under a larger indefinite delivery vehicle (IDV) contract structure, enabling Cepheid to provide molecular diagnostic testing systems, reagents, and assays to support federal healthcare operations. Cepheid's federal contracting portfolio demonstrates specialized expertise in infectious disease diagnostics and clinical testing solutions for defense and veteran healthcare systems. The company supplies molecular diagnostic technologies including GeneXpert systems and associated test kits designed to detect conditions such as COVID-19, influenza, respiratory syncytial virus, and other infectious diseases. This specific delivery order represents one of multiple procurement actions through the DLA and Veterans Integrated Service Networks, supporting the Department of Defense's broader medical supply chain requirements. The company maintains significant IDV vehicles with the Veterans Health Administration valued at over $35 million, positioning it as a key provider of diagnostic capability across federal healthcare infrastructure.